128 related articles for article (PubMed ID: 17049330)
21. Disposition and metabolism of F6-1alpha,25(OH)2 vitamin D3 and 1alpha,25(OH)2 vitamin D3 in the parathyroid glands of rats dosed with tritium-labeled compounds.
Komuro S; Sato M; Kanamaru H
Drug Metab Dispos; 2003 Aug; 31(8):973-8. PubMed ID: 12867483
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of all possible A-ring diastereomers at the 1- and 3-positions of 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3 (ED-71) using C2-symmetrical epoxide as a common starting material.
Kubodera N; Hatakeyama S
Anticancer Res; 2009 Sep; 29(9):3571-8. PubMed ID: 19667150
[TBL] [Abstract][Full Text] [Related]
23. 2-Methylene-19-nor-1alpha-hydroxyvitamin D3 analogs inhibit adipocyte differentiation and PPARgamma2 gene transcription.
Thomson B; Ahrens JM; Ntambi JM; DeLuca HF; Clagett-Dame M
Arch Biochem Biophys; 2007 Apr; 460(2):192-201. PubMed ID: 17257576
[TBL] [Abstract][Full Text] [Related]
24. Heat shock protein 60 causes osteoclastic bone resorption via toll-like receptor-2 in estrogen deficiency.
Koh JM; Lee YS; Kim YS; Park SH; Lee SH; Kim HH; Lee MS; Lee KU; Kim GS
Bone; 2009 Oct; 45(4):650-60. PubMed ID: 19527807
[TBL] [Abstract][Full Text] [Related]
25. [Mechanisms for formation of myeloma bone disease].
Yata K; Abe M; Matsumoto T
Clin Calcium; 2008 Apr; 18(4):438-46. PubMed ID: 18379024
[TBL] [Abstract][Full Text] [Related]
26. ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis.
Uchiyama Y; Higuchi Y; Takeda S; Masaki T; Shira-Ishi A; Sato K; Kubodera N; Ikeda K; Ogata E
Bone; 2002 Apr; 30(4):582-8. PubMed ID: 11934649
[TBL] [Abstract][Full Text] [Related]
27. An osteoprotegerin-like peptidomimetic inhibits osteoclastic bone resorption and osteolytic bone disease in myeloma.
Heath DJ; Vanderkerken K; Cheng X; Gallagher O; Prideaux M; Murali R; Croucher PI
Cancer Res; 2007 Jan; 67(1):202-8. PubMed ID: 17210700
[TBL] [Abstract][Full Text] [Related]
28. Distinctive anabolic roles of 1,25-dihydroxyvitamin D(3) and parathyroid hormone in teeth and mandible versus long bones.
Liu H; Guo J; Wang L; Chen N; Karaplis A; Goltzman D; Miao D
J Endocrinol; 2009 Nov; 203(2):203-13. PubMed ID: 19713218
[TBL] [Abstract][Full Text] [Related]
29. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
Aparna R; Subhashini J; Roy KR; Reddy GS; Robinson M; Uskokovic MR; Venkateswara Reddy G; Reddanna P
J Cell Biochem; 2008 Aug; 104(5):1832-42. PubMed ID: 18348265
[TBL] [Abstract][Full Text] [Related]
30. Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4.
Chang EJ; Kim HJ; Ha J; Kim HJ; Ryu J; Park KH; Kim UH; Lee ZH; Kim HM; Fisher DE; Kim HH
J Cell Sci; 2007 Jan; 120(Pt 1):166-76. PubMed ID: 17164294
[TBL] [Abstract][Full Text] [Related]
31. Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin.
Tanaka Y; Abe M; Hiasa M; Oda A; Amou H; Nakano A; Takeuchi K; Kitazoe K; Kido S; Inoue D; Moriyama K; Hashimoto T; Ozaki S; Matsumoto T
Clin Cancer Res; 2007 Feb; 13(3):816-23. PubMed ID: 17289872
[TBL] [Abstract][Full Text] [Related]
32. The role of the serum vitamin D binding protein in the actions of the vitamin D analog eldecalcitol (ED-71) on bone and mineral metabolism.
Brown AJ; Zhang F; Cooke NE; Ritter CS
Calcif Tissue Int; 2013 Aug; 93(2):163-71. PubMed ID: 23689467
[TBL] [Abstract][Full Text] [Related]
33. A potent analog of 1alpha,25-dihydroxyvitamin D3 selectively induces bone formation.
Shevde NK; Plum LA; Clagett-Dame M; Yamamoto H; Pike JW; DeLuca HF
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13487-91. PubMed ID: 12374862
[TBL] [Abstract][Full Text] [Related]
34. JunD suppresses bone formation and contributes to low bone mass induced by estrogen depletion.
Kawamata A; Izu Y; Yokoyama H; Amagasa T; Wagner EF; Nakashima K; Ezura Y; Hayata T; Noda M
J Cell Biochem; 2008 Mar; 103(4):1037-45. PubMed ID: 18240141
[TBL] [Abstract][Full Text] [Related]
35. Prostaglandin F(2alpha) negatively regulates bone resorption in murine osteoclast development.
Kamon M; Fujita D; Goto N; Amano H; Sakamoto K
Prostaglandins Other Lipid Mediat; 2008 Dec; 87(1-4):26-33. PubMed ID: 18638564
[TBL] [Abstract][Full Text] [Related]
36. Effect of chitosan particles and dexamethasone on human bone marrow stromal cell osteogenesis and angiogenic factor secretion.
Guzmán-Morales J; El-Gabalawy H; Pham MH; Tran-Khanh N; McKee MD; Wu W; Centola M; Hoemann CD
Bone; 2009 Oct; 45(4):617-26. PubMed ID: 19540373
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.
Morko J; Kiviranta R; Mulari MT; Ivaska KK; Väänänen HK; Vuorio E; Laitala-Leinonen T
Bone; 2009 Apr; 44(4):717-28. PubMed ID: 19118660
[TBL] [Abstract][Full Text] [Related]
38. [Current Topics on Vitamin D. The role of active forms of vitamin D in regulation of bone remodeling].
Nakamichi Y; Takahashi N
Clin Calcium; 2015 Mar; 25(3):395-402. PubMed ID: 25716813
[TBL] [Abstract][Full Text] [Related]
39. 1,25-Dihydroxy-19-nor-vitamin D(2), a vitamin D analog with reduced bone resorbing activity in vitro.
Holliday LS; Gluck SL; Slatopolsky E; Brown AJ
J Am Soc Nephrol; 2000 Oct; 11(10):1857-1864. PubMed ID: 11004216
[TBL] [Abstract][Full Text] [Related]
40. Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantly.
Reddy GS; Robinson M; Wang G; Palmore GT; Gennaro L; Vouros P; De Clercq P; Vandewalle M; Young W; Ling S; Verstuyf A; Bouillon R
Arch Biochem Biophys; 2007 Apr; 460(2):254-61. PubMed ID: 17196157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
